scholarly journals TCT-737 Baseline growth differentiation factor 15 (GDF15) is an independent predictor of reverse left atrial remodeling and mortality at 1-year following Transcatheter Aortic Valve Replacement

2016 ◽  
Vol 68 (18) ◽  
pp. B298
Author(s):  
Juyong Kim ◽  
Yukari Kobayashi ◽  
Daniel Brenner ◽  
Kegan Moneghetti ◽  
Ryan O'Malley ◽  
...  
2018 ◽  
Vol 35 (11) ◽  
pp. 1713-1720 ◽  
Author(s):  
Vien T. Truong ◽  
Eugene Chung ◽  
Sherif Nagueh ◽  
Dean Kereiakes ◽  
Jennifer Schaaf ◽  
...  

2011 ◽  
Vol 9 (2) ◽  
pp. 126 ◽  
Author(s):  
Sameer Gafoor ◽  
◽  
◽  
◽  
◽  
...  

Many patients have now been able to receive transcatheter aortic valve replacement (TAVR) therapy for severe aortic stenosis. These patients have atrial fibrillation and are placed on warfarin for stroke prophylaxis. The opportunity for treatment with left atrial appendage occlusion (LAAO) in place of warfarin for this population exists, especially for those with increased bleeding risk. This paper discusses the prevalence and aetiology of stroke in patients presenting for TAVR (with a focus on the risk from chronic and acute atrial fibrillation) and also the benefit of LAAO closure in this population.


Sign in / Sign up

Export Citation Format

Share Document